Status:

RECRUITING

Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity

Lead Sponsor:

Leiden University Medical Center

Conditions:

Vaccine-Preventable Diseases

Eligibility:

All Genders

20-40 years

Phase:

NA

Brief Summary

Rationale Causing a wide range of infectious diseases, including pneumonia, otitis media and meningitis, S. pneumoniae represents an important global health problem. Pneumococcal vaccines are clinical...

Eligibility Criteria

Inclusion

  • Participants between the ages of 20 and 40 years old
  • Participants should be generally healthy and without substantial co-morbidities, including all auto-immune diseases that are being actively treated with immunosuppressive therapy. Patients with chronic diseases that do not require immunosuppressive therapy and are stable, defined as not requiring change of therapy or hospitalization in the six weeks preceding study enrollment, might be eligible for this study.

Exclusion

  • BMI \> 30 kg/m2
  • Pregnancy at time of inclusion
  • Breastfeeding during the course of the study
  • Documented pneumococcal vaccination and/or infection
  • Pneumococcal infection is defined as any infection that is microbiologically confirmed to be caused by S. pneumoniae (e.g. positive blood or sputum cultures for S. pneumoniae, positive urine S. pneumoniae antigen test)
  • Documented HIV infection
  • Documented primary immune disorder or primary coagulopathy
  • Use of immunosuppressive medication or anticoagulants
  • Known hypersensitivity to any of the vaccine components
  • Recent (i.e. \<4 weeks before inclusion) surgery in axillar area or major surgery elsewhere
  • Vaccination with any vaccine \< 1 month before inclusion
  • Subjects vaccinated 1 - 6 months before enrolment can be included into the study. Study vaccine will be injected in the contralateral arm.
  • Fever at time of inclusion

Key Trial Info

Start Date :

April 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 15 2024

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT06202703

Start Date

April 15 2023

End Date

October 15 2024

Last Update

January 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Leiden University Medical Center

Leiden, Netherlands, 2333ZA